Dr. Patrick McCarthy with Genesee BioMedical CEO Matt Dambeck in scrubs, marking the first implant of the TransForm McCarthy Mitral Annuloplasty Ring at Northwestern Memorial Hospital.

We’re proud to share a groundbreaking milestone in mitral valve repair. Congratulations to Dr. Patrick McCarthy and the world-class team at Northwestern Memorial Hospital for completing the first-ever implant of the TransForm™ McCarthy Mitral Annuloplasty Ring.

At Genesee BioMedical, we are honored to have partnered with Dr. McCarthy and his team in the development of this innovative device. The TransForm™ ring was designed to combine precision, flexibility, and minimally invasive compatibility, giving surgeons a versatile solution for complex mitral valve repair procedures.

This first implant marks more than just a procedural success — it represents years of collaboration between surgeons and engineers, focused on solving real surgical challenges and improving outcomes for patients worldwide.

Why TransForm™ Matters

The TransForm™ McCarthy Mitral Annuloplasty Ring was engineered to:

  • Support open, port-access, and robotic-assisted mitral valve repair procedures.

  • Provide a semi-rigid yet flexible design, adapting from a “D” to an “O” shape to mimic the heart’s natural motion.

  • Deliver consistent, reliable outcomes in complex mitral repair.

Looking Ahead

We are excited to continue working with clinical partners as the TransForm™ ring becomes more widely evaluated and adopted. Each step forward reinforces our mission to co-develop solutions with surgeons that advance cardiac care worldwide.

Congratulations again to Dr. McCarthy and the Northwestern team for pioneering this achievement in cardiac surgery. We look forward to many more milestones together.